Get the Stockscreener App
0.6271
1.08%
0.0067
After Hours:
.64
0.0129
+2.06%
Outset Medical Inc stock is traded at $0.6271, with a volume of 795.46K.
It is up +1.08% in the last 24 hours and up +0.98% over the past month.
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.
See More
Previous Close:
$0.6204
Open:
$0.645
24h Volume:
795.46K
Relative Volume:
0.44
Market Cap:
$32.67M
Revenue:
$116.43M
Net Income/Loss:
$-159.18M
P/E Ratio:
-0.1787
EPS:
-3.51
Net Cash Flow:
$-140.00M
1W Performance:
+13.61%
1M Performance:
+0.98%
6M Performance:
-80.03%
1Y Performance:
-85.24%
1-Day Range:
$0.621
$0.6799
1-Week Range:
$0.52
$0.6799
52-Week Range:
$0.435
$6.37
Outset Medical Inc Stock (OM) Company Profile
Name
Outset Medical Inc
Sector
Industry
Phone
669-231-8200
Address
3052 ORCHARD DRIVE, SAN JOSE
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-17-23 | Initiated | CL King | Neutral |
| Nov-11-22 | Initiated | RBC Capital Mkts | Outperform |
| Jul-14-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-17-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-18-21 | Initiated | Cowen | Outperform |
| Apr-19-21 | Initiated | Wells Fargo | Overweight |
| Dec-16-20 | Initiated | Oppenheimer | Perform |
| Oct-12-20 | Initiated | Barclays | Overweight |
| Oct-12-20 | Initiated | BofA Securities | Buy |
| Oct-12-20 | Initiated | Goldman | Buy |
| Oct-12-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-12-20 | Initiated | SVB Leerink | Mkt Perform |
| Oct-12-20 | Initiated | Stifel | Buy |
View All
Outset Medical Inc Stock (OM) Latest News
Outset Medical Inc (OM) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com
OM Investors Have Opportunity to Lead Outset Medical, Inc. Securities Fraud Lawsuit - GuruFocus.com
Outset Partners with User Interviews for Qualitative Research - GlobeNewswire Inc.
Deadline on October 28th coming up in Lawsuit for Investors in Outset Medical, Inc. (NASDAQ: OM) - openPR
DEADLINE ALERT for OM, SAGE, and SMCI: The Law Offices of - GlobeNewswire
FINAL OM DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Outset Medical, Inc. Investors to Join the Class Action Lawsuit! - AccessWire
Outset Medical, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your RightsOM - PR Newswire
OM DEADLINE: ROSEN, A RANKED AND LEADING FIRM, Encourages - GlobeNewswire
OM Investors Have Opportunity to Lead Outset Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus.com
Glancy Prongay & Murray LLP Reminds Investors of Looming - GlobeNewswire
SHAREHOLDER ALERT: Holzer & Holzer, LLC Reminds Investors of the October 28, 2024 Lead Plaintiff Deadline in Class Action Lawsuits Filed on Behalf of Verve Therapeutics, Inc. (VERV), Sage Therapeutics, Inc. (SAGE), and Outset Medical, Inc. (OM) Sha - Morningstar
SHAREHOLDER ALERT: Holzer & Holzer, LLC Reminds Investors - GlobeNewswire
Outset Medical, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. ... - The Bakersfield Californian
Outset Medical, Inc. Investors: Please contact the Portnoy - GlobeNewswire
New Research Highlights Improvements in Quality of Life and - GlobeNewswire
New Research Highlights Improvements in Quality of Life and Caregiver Experience for Home Hemodialysis Patients Using Tablo - StockTitan
OM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
The Gross Law Firm Notifies Shareholders of Outset Medical, - GlobeNewswire
Outset Medical to Report Third Quarter 2024 Financial Results on Wednesday, November 6, 2024 - GlobeNewswire
OM Deadline: OM Investors Have Opportunity to Lead Outset Medical, Inc. Securities Fraud Lawsuit - The Malaysian Reserve
2024-10-23 | OM Stockholders Have Opportunity to Lead Outset Medical, Inc. Class Action LawsuitContact Bronstein, Gewirtz and Grossman, LLC Today! | NDAQ:OM | Press Release - Stockhouse Publishing
Levi & Korsinsky Notifies Shareholders of Outset Medical, Inc.(OM) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Outset Medical, ZoomInfo, and Super Micro and Encourages Investors to Contact the Firm - GlobeNewswire
OM FINAL DEADLINE: RLF, A GLOBAL AND LEADING LAW FIRM, - GlobeNewswire
OM FINAL DEADLINE: RLF, A GLOBAL AND LEADING LAW FIRM, Encourages Outset Medical, Inc. - The Bakersfield Californian
OM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - AccessWire
OM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - AccessWire
OM DEADLINE: RLF, A TOP-RANKED LAW FIRM, Encourages Outset - GlobeNewswire
Berman Tabacco Announces that it has Filed a New Class Action Complaint Against Outset Medical, Inc. with an Expanded Class Period - Marketscreener.com
Class Action Lawsuit Against Outset Medical (NASDAQ:OM) - TipRanks
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Outset Medical, Inc.OM - PR Newswire
Outset Medical (OM) Shares Down 94% Since Disclosing FDA - GlobeNewswire
Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - GlobeNewswire Inc.
Investors in Outset Medical, Inc. Should Contact The Gross - GlobeNewswire
OM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Outset - GlobeNewswire
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors to Secure Counsel - The Bakersfield Californian
Levi & Korsinsky Reminds Outset Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024OM - PR Newswire
Shareholders of Outset Medical, Inc. Should Contact Levi & - GlobeNewswire
The Gross Law Firm Reminds Outset Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024OM - PR Newswire
Outset Medical Inc Stock (OM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):